You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

89Zr-DFO-MSTP2109A

Showing 76 - 100 of 124
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Amsterdam (89Zirconium-labeled ipilimumab)

Recruiting
  • Melanoma
  • 89Zirconium-labeled ipilimumab
  • Amsterdam, Noord-Holland, Netherlands
    VU Medical Center
Apr 14, 2021

Prostate Cancer Trial in New York (89ZR-DF-IAB2M, 68Ga-PSMA-HBED-CC)

Completed
Has Results
  • Prostate Cancer
  • New York, New York
    Weill Cornell Medicine
Sep 18, 2020

Metastatic Prostate Cancer Trial in New York ([89Zr]Df-IAB2M)

Completed
  • Metastatic Prostate Cancer
  • [89Zr]Df-IAB2M
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 10, 2020

Prostate Cancer Trial in Scottsdale ([89Zr]Df-IAB2M)

Completed
  • Prostate Cancer
  • [89Zr]Df-IAB2M
  • Scottsdale, Arizona
    Arizona Urology Specialists
Feb 10, 2020

Inflammatory Breast Carcinoma Trial in Boston (89Zr-bevacizumab, FDG-PET/CT, MRI scan)

Completed
  • Inflammatory Breast Carcinoma
  • Boston, Massachusetts
  • +1 more
Dec 10, 2019

Optimization of Anti-EGFR Therapy in Metastatic Colorectal

Completed
  • Colorectal Cancer
  • (Early) Imaging of response with [18F-]-FDG PET-CT and kinase activity profiles
  • Amsterdam, Noord Holland, Netherlands
    VU University Medical Center
Nov 3, 2020

Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

Terminated
Has Results
  • Transfusion-dependent β-thalassemia Patients
  • Cardiac Iron Overload
  • Athens, GR, Greece
  • +3 more
Oct 21, 2019

Amyloidosis Trial in Uppsala (GSK2315698 (CPHPC), GSK2398852 (unlabeled anti-SAP mAb), 89Zr-GSK2398852 (89Zr-labeled anti-SAP

Terminated
Has Results
  • Amyloidosis
  • GSK2315698 (CPHPC)
  • +2 more
  • Uppsala, Sweden
    GSK Investigational Site
Jul 16, 2019

DLBCL, Not Otherwise Specified Trial in Amsterdam, Groningen (89Zr-atezolizumab PET scans)

Recruiting
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • 89Zr-atezolizumab PET scans
  • Amsterdam, Noord-Holland, Netherlands
  • +1 more
Jun 14, 2019

Clear Cell Renal Carcinoma Trial in Nijmegen (89Zr-Girentuximab)

Completed
  • Clear Cell Renal Carcinoma
  • 89Zr-Girentuximab
  • Nijmegen, Netherlands
    Radboud University
Mar 29, 2019

Hepatocellular Carcinoma Non-resectable Trial in Jinan (Conventional TACE, Deferoxamine and conventional TACE)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • Conventional TACE
  • Deferoxamine and conventional TACE
  • Jinan, Shandong, China
    960th hospital of PLA
Feb 20, 2019

Solid Tumor, Adult Trial in Suzhou (89Zr-KN035)

Unknown status
  • Solid Tumor, Adult
  • 89Zr-KN035
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 4, 2018

Glioblastoma Trial in New York (drug, device, other)

Completed
Has Results
  • Glioblastoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 22, 2019

Cancer, Tumors Trial in Amsterdam (GSK2849330, 89Zr-GSK2849330)

Completed
  • Cancer
  • Neoplasms
  • Amsterdam, Netherlands
  • +1 more
Feb 19, 2019

Breast Cancer Trial in Saint Louis (89Zr-Trastuzumab Human Dosimetry and Safety, HER2 Positive Lesion Detection and Safety)

Completed
  • Breast Cancer
  • 89Zr-Trastuzumab Human Dosimetry and Safety
  • HER2 Positive Lesion Detection and Safety
  • Saint Louis, Missouri
    Washington University School of Medicine @ Barnes-Jewish Hospita
Oct 1, 2018

Positron-Emission Tomography, Immunomodulation, Metastatic Solid Malignancies Trial in Scottsdale, New York, Philadelphia

Completed
  • Positron-Emission Tomography
  • +3 more
  • ⁸⁹Zr-Df-IAB22M2C Infusion
  • Scottsdale, Arizona
  • +2 more
Sep 17, 2018

Cardiovascular Diseases, Heart Diseases, Beta-Thalassemia Trial in United States (Deferoxamine, Deferiprone (L1))

Terminated
Has Results
  • Cardiovascular Diseases
  • +2 more
  • Los Angeles, California
  • +5 more
Feb 1, 2018

Intracerebral Hemorrhage Trial in Boston (Deferoxamine Mesylate)

Completed
  • Intracerebral Hemorrhage
  • Deferoxamine Mesylate
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 11, 2018

Intracranial Aneurysm, Subarachnoid Hemorrhage Trial in Nijmegen, Groningen (Deferoxamine, )

Unknown status
  • Intracranial Aneurysm
  • Subarachnoid Hemorrhage
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Sep 26, 2017

Tumors Trial run by the NCI (Ziv-Aflibercept, Ganetespib)

Terminated
Has Results
  • Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2018

Advanced Gastrointestinal Cancer Trial in Amsterdam, Groningen (89Zr-AMG211, 89-ZrAMG211 PET)

Completed
  • Advanced Gastrointestinal Cancer
  • Amsterdam, Netherlands
  • +1 more
Jun 1, 2017

Non Small Cell Lung Cancer Trial in Amsterdam (89Zr-Pembrolizumab)

Unknown status
  • Non Small Cell Lung Cancer
  • Amsterdam, Noord-Holland, Netherlands
    VUMedicalCentre
Aug 14, 2017

Breast Tumors, Secondary, HER2 Positive Carcinoma of Breast Trial in Brussels (Zr89-trastuzumab)

Completed
Has Results
  • Breast Neoplasms
  • +2 more
  • Brussels, Belgium
    Jules Bordet Institut
Mar 7, 2017

Glioma Trial in Shanghai (89Zr-ABT806 PET)

Unknown status
  • Glioma
  • 89Zr-ABT806 PET
  • Shanghai, China
    Huashan hospital, Fudan university
Feb 15, 2017

Metastatic Colorectal Cancer Trial run by the NCI (Cetuximab, BAY 43-9006)

Completed
Has Results
  • Metastatic Colorectal Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2017